Fig. 1From: Comparison of the drug retention and reasons for discontinuation of tumor necrosis factor inhibitors and interleukin-6 inhibitors in Japanese patients with elderly-onset rheumatoid arthritis—the ANSWER cohort studyAdjusted drug retention and adverse event among TNFi and IL-6i patients TNFi tumor necrosis factor inhibitors, IL-6i interleukin-6 inhibitors. a Adjusted drug retention between TNFi and IL-6i. b Adjusted cumulative incidence of drug discontinuation due to lack of effectiveness between TNFi and IL-6i. c Adjusted cumulative incidence of drug discontinuation due to adverse event between TNFi and IL-6i. d Adjusted cumulative incidence of drug discontinuation due to remission between TNFi and IL-6iBack to article page